Physiologically Based Pharmacokinetic (PBPK) Modeling of Disposition of Epiroprim in Humans
- 1 October 2003
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 92 (10) , 1990-2007
- https://doi.org/10.1002/jps.10461
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Prediction of Pharmacokinetics Prior to In Vivo Studies. II. Generic Physiologically Based Pharmacokinetic Models of Drug DispositionJournal of Pharmaceutical Sciences, 2002
- Pharmacokinetics of the M1-agonist talsaclidine in mouse, rat, rabbit and monkey, and extrapolation to manXenobiotica, 2000
- Extensive Biliary Excretion of the Sulfasalazine Analogue, Susalimod, but Different Concentrations in the Bile Duct in Various Animal Species Correlating to Species‐Specific Hepatobiliary ToxicityBasic & Clinical Pharmacology & Toxicology, 1999
- Interspecies Pharmacokinetic Comparisons and Allometric Scaling of Napsagatran, a Low Molecular Weight Thrombin InhibitorJournal of Pharmacy and Pharmacology, 1999
- Physiological Parameter Values for Physiologically Based Pharmacokinetic ModelsToxicology and Industrial Health, 1997
- Interspecies Scaling: Predicting Pharmacokinetic Parameters of Antiepileptic Drugs in Humans from Animals with Special Emphasis on ClearanceJournal of Pharmaceutical Sciences, 1996
- Culture matrix configuration and composition in the maintenance of hepatocyte polarity and functionBiomaterials, 1996
- A new extrapolation method from animals to man: Application to a metabolized compound, mofaroteneLife Sciences, 1995
- Pharmacokinetic Scale-up: Accurate Prediction of Human Pharmacokinetic Profiles from Animal DataJournal of Pharmaceutical Sciences, 1985
- Interspecies Pharmacokinetic Scaling and the Evolutionary-Comparative ParadigmDrug Metabolism Reviews, 1984